German generics drugmaker Dermapharm put up for sale, say sources: Reuters
Privately-held German generic drugmaker Dermapharm has attracted interest from buyout groups in a potential 1 billion euro ($1.1 billion) deal after being put up for sale by its founder, sources told Reuters.





